Abstract

Type 2 diabetes (T2D) is a widespread disease affecting millions in every continental population. Pancreatic β-cells are central to the regulation of circulating glucose, but failure in the maintenance of their mass and/or functional identity leads to T2D. Long non-coding RNAs (lncRNAs) represent a relatively understudied class of transcripts which growing evidence implicates in diabetes pathogenesis. T2D-associated single nucleotide polymorphisms (SNPs) have been identified in lncRNA loci, although these appear to function primarily through regulating β-cell proliferation. In the last decade, over 1100 lncRNAs have been catalogued in islets and the roles of a few have been further investigated, definitively linking them to β-cell function. These studies show that lncRNAs can be developmentally regulated and show highly tissue-specific expression. lncRNAs regulate neighbouring β-cell-specific transcription factor expression, with knockdown or overexpression of lncRNAs impacting a network of other key genes and pathways. Finally, gene expression analysis in studies of diabetic models have uncovered a number of lncRNAs with roles in β-cell function. A deeper understanding of these lncRNA roles in maintaining β-cell identity, and its deterioration, is required to fully appreciate the β-cell molecular network and to advance novel diabetes treatments.

Highlights

  • Type 2 diabetes (T2D) is a worldwide epidemic affecting over 400 million people [1]

  • LncRNA-p3134 was significantly increased in serum and enriched in the circulating exosomes of humans with diabetes and mouse models. Overexpression of this Long non-coding RNAs (lncRNAs) resulted in increased expression of β-cell-specific genes such as Pdx1, MafA and Slc2a2, leading to increased glucose-stimulated insulin secretion (GSIS) via activation of the PI3K/Akt/mTOR pathway. lncRNA-p3134 overexpression provided a protective effect against glucotoxicity-mediated apoptosis, thereby maintaining β-cell mass for a sufficient insulin secretory response [53]

  • Pancreatic β-cells express over a thousand lncRNAs, only a small percentage of these have been studied in detail

Read more

Summary

Introduction

Type 2 diabetes (T2D) is a worldwide epidemic affecting over 400 million people [1]. A combination of genetic and environmental risk factors results in a mismatch between the insulin released and the insulin required to correctly regulate blood glucose levels. The regulation of this locus differs between cell types and the difficulty in accessing human islet tissue and the lack of conserved lncRNAs in the mouse genome means relatively few studies have directly investigated the function of CDKN2B-AS1 in β-cells. The SNPs at this locus are hypothesised to mediate diabetes susceptibility by disrupting the expression of KCNQ1OT1, altering the imprinting within this gene cluster and leading to the overexpression of CDKN1C and impaired β-cell proliferation [37].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call